Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis

BACKGROUND: Fibroblast growth factor receptor 3 (FGFR3) mutations have been implicated in urothelial tumorigenesis. FGFR3 inhibitors are being explored in clinical trials. OBJECTIVE: We aimed to study the association between FGFR3 mutations and survival in urothelial carcinoma. DESIGN, SETTING, AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalid, Sidra, Basulaiman, Bassam Mohammed, Emack, Jeffrey, Booth, Christopher M., Duran, Ignacio, Robinson, Andrew G., Berman, David, Smoragiewicz, Martin, Amir, Eitan, Vera-Badillo, Francisco E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Urothelial Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317902/
https://www.ncbi.nlm.nih.gov/pubmed/34337469
http://dx.doi.org/10.1016/j.euros.2020.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317902/
https://www.ncbi.nlm.nih.gov/pubmed/34337469
http://dx.doi.org/10.1016/j.euros.2020.08.008

Ejemplares similares